The U1-like snRNA variants are ubiquitously expressed, and show features characteristic of spliceosomal snRNAs. (A) Northern blot analysis of snRNA variants in HeLa cells. The following probes were used: u1a (lane 1), u1a5 (lane 2), u1a6 (lane 3), u1a7 (lane 4), and 5s (lane 5). Positions of RNA size markers are indicated on the left. (B) RNA samples prepared from HeLa cells and a range of human tissues obtained from distinct developmental stages were analyzed by Northern blot analysis. The U1 snRNA variants detected by the specific oligonucleotide probes are indicated on the left and tissue types are indicated above the panels. RNA isolated from HeLa cells (lanes 1,10,11,19,20,28), adult tissues (lanes 2–9), 6-week embryonic tissue (lanes 12–18), and 12-week embryonic tissue (lanes 21–27). (C) Northern blot analysis of immunoprecipitation (IP) experiments. HeLa nuclear extract was subjected to IP using an anti-m3G/m7G-cap monoclonal antibody (mAbH20; lane 1), an anti-snRNA-m3G-cap polyclonal antiserum (r-R1131; lane 3), or an anti-Sm-protein monoclonal antibody (mAbY12; lane 5), respectively. Controls were included utilizing mouse immunoglobulin (mIgG, lanes 2,6) and normal rabbit serum (NRS, lane 4), respectively. Immunoprecipitated RNA was purified and analyzed by Northern blot analysis. U1 snRNA variants or 5S RNA detected by the specific oligonucleotide probes are indicated. (D) Northern blot analysis of electrophoretic mobility shift assays (EMSA) using nuclear extract preparations; nuclear extract (NE; lanes 1,3,5,7); nuclear RNA (RNA; lanes 2,4,6,8). The U1 snRNA variants detected by specific oligonucleotide probes are indicated above the panels. The position of RNA–protein complexes (snRNP) and free snRNA molecules (snRNA) are indicated.